Mosaic ImmunoEngineering Inc.

CPMVOTCHealthcare● Active

$0.69

+$0.02(+3.03%)

Market Cap$5028940

P/E Ratio—

52W High$1.05

52W Low$0.3

Avg Volume387

Open$0.69

Beta-0.79

Earnings Financials Revenue

Mosaic ImmunoEngineering Inc. (CPMV) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CPMV · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: May 20, 2026

EPS Actual

-$0.02

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 20, 2026

After Market Close

CPMV reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 20, 2026	—	-$0.02	—	—	—	—
— Q2 FY2026	Apr 15, 2026	—	-$0.02	—	—	—	—
— Q4 FY2025	Nov 19, 2025	—	-$0.02	—	—	—	—
— Q3 FY2025	Aug 19, 2025	—	-$0.02	—	—	—	—
— Q2 FY2025	May 20, 2025	—	-$0.03	—	—	—	—
— Q4 FY2024	Nov 19, 2024	—	-$0.03	—	—	—	—
— Q3 FY2024	Aug 14, 2024	—	-$0.04	—	—	—	—
— Q2 FY2024	Apr 15, 2024	—	-$0.04	—	—	—	—

Q2 FY2026

May 20, 2026

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 15, 2026

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2025

Nov 19, 2025

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 19, 2025

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 20, 2025

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Nov 19, 2024

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 14, 2024

EPS Actual

-$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Apr 15, 2024

EPS Actual

-$0.04

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for CPMV.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 20, 2026	—	$0.70	$0.70	+0.00%
— Q2 FY2026	Apr 15, 2026	—	$0.70	$0.70	+0.00%
— Q4 FY2025	Nov 19, 2025	—	$0.60	$0.60	+0.00%
— Q3 FY2025	Aug 19, 2025	—	$0.50	$0.50	-0.99%
— Q2 FY2025	May 20, 2025	—	$0.54	$0.54	+0.00%
— Q4 FY2024	Nov 19, 2024	—	$0.99	$1.00	+1.01%
— Q3 FY2024	Aug 14, 2024	—	$1.08	$1.06	-1.85%
— Q2 FY2024	Apr 15, 2024	—	$0.55	$0.33	-40.21%

Q2 FY2026+0.00%

Report Date

May 20, 2026

EPS Beat/Miss

—

Price Before

$0.70

Price After

$0.70

Q2 FY2026+0.00%

Report Date

Apr 15, 2026

EPS Beat/Miss

—

Price Before

$0.70

Price After

$0.70

Q4 FY2025+0.00%

Report Date

Nov 19, 2025

EPS Beat/Miss

—

Price Before

$0.60

Price After

$0.60

Q3 FY2025-0.99%

Report Date

Aug 19, 2025

EPS Beat/Miss

—

Price Before

$0.50

Price After

$0.50

Q2 FY2025+0.00%

Report Date

May 20, 2025

EPS Beat/Miss

—

Price Before

$0.54

Price After

$0.54

Q4 FY2024+1.01%

Report Date

Nov 19, 2024

EPS Beat/Miss

—

Price Before

$0.99

Price After

$1.00

Q3 FY2024-1.85%

Report Date

Aug 14, 2024

EPS Beat/Miss

—

Price Before

$1.08

Price After

$1.06

Q2 FY2024-40.21%

Report Date

Apr 15, 2024

EPS Beat/Miss

—

Price Before

$0.55

Price After

$0.33

Beat Rate0 / 8 quarters

Largest Move-40.21% (Q2 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Mosaic ImmunoEngineering Inc. (CPMV) most recently reported earnings on May 20, 2026 for Q2 FY2026, posting EPS of $-0.02 (in line with the analyst consensus of —). The next CPMV earnings date is expected around September 1, 2026.

Each quarter, investors track CPMV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CPMV revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

CPMV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

CPMV earnings · 4 questions

Mosaic ImmunoEngineering Inc.'s next earnings report is expected around September 1, 2026. CPMV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CPMV historically reports after market close (AMC).

CPMV earnings datewhen is CPMV earningsCPMV next earnings datewhen does CPMV report earningsCPMV earnings calendar

▸ Source: FMP · Mosaic ImmunoEngineering Inc. SEC filings · US GAAP · Mosaic ImmunoEngineering Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026